Navigation Links
35th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser
Date:10/4/2010

ts with metastatic breast cancer (embargo: 10 October, 15:30 Milan time)

Patients with metastatic breast cancer live longer on average if their chemotherapy is continued after their cancer is brought under control, a new meta-analysis shows.

J. O'Shaughnessy, US

Iniparib extends overall survival in metastatic triple-negative breast cancer: final Phase-II results (embargo: 10 October, 15:30 Milan time)

Women with an aggressive subtype of metastatic breast cancer appear to live longer when treated with iniparib plus chemotherapy, compared to chemotherapy alone, the results of a randomized Phase-II trial show.

M. Pavel, DE

Phase-III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors (embargo: 11 October, 10:30 Milan time)

The results of a large Phase-III clinical trial have shown that the drug everolimus delays tumor progression in patients with a hard-to-treat group of rare cancers that affect particular hormone-producing cells.

B. Koczwara, AU

Fertility concerns of cancer survivors inadequately addressed, study finds (embargo: 11 October, 12:30 Milan time)

Many cancer survivors experience changes in sexual function that leave them feeling guilt and a longing for intimacy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.

Y. Loriot, FR

Sexual issues a major concern for cancer patients taking new targeted drugs (embargo: 11 October, 12:30 Milan time)

New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.

B. You, FR

Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds (embargo: 11 October, 12:30 Milan time)

Substantial inconsistencies in a basic aspect of
'/>"/>

SOURCE European Society for Medical Oncology (ESMO)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
2. European Masters of Poker Italy Online Qualification in Full Swing
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
5. American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010
6. Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010
7. Stryker to Host Conference Call on October 19, 2010
8. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
9. Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008
10. Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase
11. Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - ... today,announced that data from a 36-week, randomized, ... oral 0.6 mg,dose of laquinimod given daily ... by 38 percent in RRMS,patients and was ...
... pivotal phase III study in women with recurrent ... 2007,/PRNewswire-FirstCall/ -- A new study further supports the ... being,studied for the treatment of ovarian cancer. The ... protein, which triggers,a series of events that selectively ...
Cached Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5
(Date:5/18/2013)... (PRWEB) May 18, 2013 John Ravera, D.D.S., ... the addition of a new member to his dental team, ... worked in the field for over 10 years. She received ... honors, and was elected a member of Sigma Pi Alpha, ... profession. Marino enjoys working with patients of all ages, helping ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... 2013 Creation's Gold has released its ... which features unmatched potency and purity that serves to ... up to provide the very best quality products to ... their wellness goals. The goal is to provide people ... lives. We started by supplying only the best premium ...
(Date:5/17/2013)... NEW YORK, May 18, 2013. Chronic trauma can inflict ... anxiety. Previous imaging studies of people with post-traumatic stress ... can over-or under-react in response to stressful tasks, such ... photo of a threatening face. Now, researchers at NYU ... what happens in the brains of combat veterans with ...
(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...
Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour ... indoor and outdoor allergy symptoms. The product is available for ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) , ...
... , , , ... workers in today,s economy add additional stress to already overworked employees, ... National Safety Council estimates that employers pay almost $1 billion per ... indirect costs related to workers, compensation. , , ...
... September 2009: The REVISE Study (Reveal in the Investigation of ... in the United Kingdom, previously thought to be suffering from ... fact had symptoms as a result of an abnormal pattern ... REVISE is the first study to show that, ...
... VidaGas propane energy company secures $1.4M investment from ... Sept. 1 VillageReach, the Seattle-based social enterprise that increases ... Foundation for Community Development (FDC), a Mozambique non profit that ... Oasis Fund, a European commercial investment fund specializing in social ...
... ... a Complete Electronic System to ,Improve Patient Care , ... Atlanta, GA (Vocus) September 1, 2009 -- Thousands ... health records. While this has made improvements in patient care, an electronic health records ...
... BUENOS AIRES, Argentina, Sept. 1 Frost & ... 2009 Customer Value Leadership Award in the Latin American computed ... continuously add value to new and existing healthcare providers, positioning ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...
Cached Medicine News:Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 2Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 3Health News:Syncope and implantable loop recorders: Good value for money? 2Health News:Syncope and implantable loop recorders: Good value for money? 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 2Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 4Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 2Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 3Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 4Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4
... Surgical Markers allows the surgeon ... with a scrub-resistant, gentian violet ... are provided sterile, with a ... in peel pouches. Micro tip ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Broad tip, gentian violet, sterile, disposable...
Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide....
Medicine Products: